104 related articles for article (PubMed ID: 8034974)
1. A cytotoxicity assay utilizing a fluorescent dye that determines accurate surviving fractions of cells.
Sellers JR; Cook S; Goldmacher VS
J Immunol Methods; 1994 Jun; 172(2):255-64. PubMed ID: 8034974
[TBL] [Abstract][Full Text] [Related]
2. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
Wierda WG; Mehr DS; Kim YB
J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
[TBL] [Abstract][Full Text] [Related]
3. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF).
Kolber MA; Quinones RR; Gress RE; Henkart PA
J Immunol Methods; 1988 Apr; 108(1-2):255-64. PubMed ID: 3258339
[TBL] [Abstract][Full Text] [Related]
4. Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (CFDA) and comparison with conventional 51CR release assay.
Provinciali M; Di Stefano G; Fabris N
J Immunol Methods; 1992 Oct; 155(1):19-24. PubMed ID: 1401964
[TBL] [Abstract][Full Text] [Related]
5. A novel in vitro screening assay for trypanocidal activity using the fluorescent dye BCECF-AM.
Obexer W; Schmid C; Brun R
Trop Med Parasitol; 1995 Mar; 46(1):45-8. PubMed ID: 7631128
[TBL] [Abstract][Full Text] [Related]
6. Limitations of the fluorescent probe viability assay.
Massaro EJ; Elstein KH; Zucker RM; Bair KW
Mol Toxicol; 1989; 2(4):271-84. PubMed ID: 2490980
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-based viability assay for studies of reactive drug intermediates.
Leeder JS; Dosch HM; Harper PA; Lam P; Spielberg SP
Anal Biochem; 1989 Mar; 177(2):364-72. PubMed ID: 2729556
[TBL] [Abstract][Full Text] [Related]
8. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
[TBL] [Abstract][Full Text] [Related]
9. A differential assay of NK-cell-mediated cytotoxicity in K562 cells revealing three sequential membrane impairment steps using three-color flow-cytometry.
Kasatori N; Ishikawa F; Ueyama M; Urayama T
J Immunol Methods; 2005 Dec; 307(1-2):41-53. PubMed ID: 16246359
[TBL] [Abstract][Full Text] [Related]
10. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the uptake of the fluorescent marker 2',7'-bis-(2-carboxyethyl)-5(and-6)-carboxyfluorescein (BCECF) by hydrogenosomes in Trichomonas vaginalis.
Scott DA; Docampo R; Benchimol M
Eur J Cell Biol; 1998 Jun; 76(2):139-45. PubMed ID: 9696354
[TBL] [Abstract][Full Text] [Related]
12. Efflux of bis-carboxyethyl-carboxyfluorescein (BCECF) by a novel ATP-dependent transport mechanism in epithelial cells.
Allen CN; Harpur ES; Gray TJ; Simmons NL; Hirst BH
Biochem Biophys Res Commun; 1990 Oct; 172(1):262-7. PubMed ID: 2222473
[TBL] [Abstract][Full Text] [Related]
13. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line.
Monteiro-Riviere NA; Inman AO; Zhang LW
Toxicol Appl Pharmacol; 2009 Jan; 234(2):222-35. PubMed ID: 18983864
[TBL] [Abstract][Full Text] [Related]
14. Single-colour flow cytometric assay to determine NK cell-mediated cytotoxicity and viability against non-adherent human tumor cells.
Thakur A; Zaman A; Hummel J; Jones K; Hortelano G
Biotechnol Lett; 2012 Mar; 34(3):447-53. PubMed ID: 22187077
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of methods for determining 6-hydroxydopamine cytotoxicity.
Tiffany-Castiglioni E; Perez-Polo JR
In Vitro; 1980 Jul; 16(7):591-9. PubMed ID: 7409829
[TBL] [Abstract][Full Text] [Related]
16. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.
Neri S; Mariani E; Meneghetti A; Cattini L; Facchini A
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1131-5. PubMed ID: 11687452
[TBL] [Abstract][Full Text] [Related]
17. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF.
Bachmeier CJ; Trickler WJ; Miller DW
J Pharm Sci; 2004 Apr; 93(4):932-42. PubMed ID: 14999730
[TBL] [Abstract][Full Text] [Related]
18. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity as measured by trypan blue as a potentially confounding variable in the in vitro alkaline elution/rat hepatocyte assay.
Elia MC; Storer RD; Harmon LS; Kraynak AR; McKelvey TW; Hertzog PR; Keenan KP; DeLuca JG; Nichols WW
Mutat Res; 1993 Jun; 291(3):193-205. PubMed ID: 7685060
[TBL] [Abstract][Full Text] [Related]
20. Different techniques for drug cytotoxicity evaluation on MCF-7 human breast cancer cell line.
Leonessa F; Coialbu T; Toma S
Anticancer Res; 1986; 6(6):1291-6. PubMed ID: 3813485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
